av/lianbio--big.svg

NASDAQ:LIAN

LianBio

  • Stock

0.32

USD last updated 20/08 01:59:44

Last Close

0.32

16/01 21:00

Market Cap

34.47M

Beta: -

Volume Today

2.49M

Avg: 224.13K

PE Ratio

−4.99

PFCF: −5.23

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03...Show More

    Earnings

    Earnings per Share (Estimate*)

    -12-10-8-6-4-22020-09-302021-11-022022-05-122023-05-112024-05-09

    Revenue (Estimate*)

    1M2M3M4M5M2020-09-302021-11-022022-05-122023-05-112024-05-09

    *Estimate based on analyst consensus